alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
knwn_ex102.htm

EXHIBIT 10.2
  
 AMENDMENT NO. 8 TO
 CONVERTIBLE REDEEMABLE PROMISSORY NOTE 
 DATED JANUARY 31, 2018
  
 This AMENDMENT NO. 8 TO CONVERTIBLE REDEEMABLE PROMISSORY NOTE dated JANUARY 31, 2018 in the principal amount of US$664,233 (this “Amendment”) is made and entered into as of December 7, 2022, by and between J3E2A2Z LP (the “Holder”), and Know Labs, Inc., a Nevada corporation f/k/a Visualant, Incorporated (the “Company”).
  
 RECITALS
  
 WHEREAS, the Company is a party to that certain Convertible Redeemable Promissory Note dated January 31, 2018 as amended (as so amended, the “Debenture”), payable to Holder (capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Debenture);
  
 WHEREAS, the Promissory Note currently has a Maturity Date of September 30, 2022; and
  
 WHEREAS, the Holder and the Company wish to amend the Promissory Note to extend the Maturity Date;
  
 AGREEMENT
  
 Now, therefore, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree to the following.
  
 1. Amendment of Maturity Date. The Maturity Date of the Debenture is hereby amended to January 30, 2023.
  
 2. Effect of Amendment.The parties hereto agree that the amendments described above are effective retroactively to September 30, 2022. Except as specifically set forth in this Amendment, the terms of the Debenture remain in full force and effect.
  
 3. Interest Rate. The interest rate is 6%.
  
 4. Counterparts. This Amendment may be executed in two (2) or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.
  
 IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first above written.
  
 (signature page follows)
   
 	 
	 1

	

	 

  
 	 Company:
	  
	 Holder:
	  

	 KNOW LABS, INC. 
	 	J3E2A2Z LP	 
	 By:
	/s/ Phillip A. Bosua 	 	By: 	/s/ Ronald P. Erickson	 
	 Name: 
	Phillip A. Bosua	 	Name:	Ronald P. Erickson	 
	 Title:
	Chief Executive Officer	 	Title:	Manager	 

  
 	 
	 2
ARMED SERVICES BOARD OF CONTRACT APPEALS 

Appeal of--

KBJ, Inc. 

Under Contract No. NNCl 1CA18C 

APPEARANCE FOR THE APPELLANT: 

) 

) 

) 

) 

) 

APPEARANCES FOR THE GOVERNMENT: 

ASBCA No. 59785 

Joseph R. Spoonster, Esq. 

Harpst Ross, Ltd. 

Uniontown, OH 

Scott W. Barber, Esq. 

NASA Chief Trial Attorney 

James T. Mahoney, Esq. 

Trial Attorney 

NASA Headquarters 

Washington, DC 

Tamika S. Laldee, Esq. 

Laura A. Henry, Esq. 

Trial Attorneys 

NASA Glenn Research Center, OH 

ORDER OF DISMISSAL 

The dispute has been settled. The appeal is dismissed with prejudice. 

Dated: 2 June 2016 

inistrative Judge 

Armed Services Board 

of Contract Appeals 

I certify that the foregoing is a true copy of the Order of Dismissal of the Armed 

Services Board of Contract Appeals in ASBCA No. 59785, Appeal ofKBJ, Inc., rendered 

in conformance with the Board's Charter. 

Dated: 

JEFFREY D. GARDIN 

Recorder, Armed Services 

Board of Contract Appeals
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 3514 Introduced in Senate (IS)]

<DOC>

117th CONGRESS
  2d Session
                                S. 3514

To repeal COVID-19 vaccination requirements imposed by the District of 
                               Columbia.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            January 18, 2022

Mr. Paul (for himself, Mr. Scott of Florida, Mr. Lankford, Mr. Wicker, 
and Mr. Cramer) introduced the following bill; which was read twice and 
referred to the Committee on Homeland Security and Governmental Affairs

_______________________________________________________________________

                                 A BILL

 
To repeal COVID-19 vaccination requirements imposed by the District of 
                               Columbia.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Restore Parental and Consumer 
Medical Rights in the Nation's Capital Act''.

SEC. 2. REPEAL OF DC VACCINE MANDATES.

    The following shall have no force or effect:
            (1) Order 2021-148 issued by the Mayor of the District of 
        Columbia on December 22, 2021.
            (2) The Coronavirus Immunization of School Students and 
        Early Childhood Workers Amendment Act of 2021 (D.C. Act 24-
        285), enacted by the District of Columbia Council on January 
        12, 2022.
                                 <all>
```
<PAGE>   1
                                                                   EXHIBIT 11.01

                        EDUCATION MANAGEMENT CORPORATION

                     CALCULATION OF OUTSTANDING SHARES FOR
                         EARNINGS PER SHARE CALCULATION

<TABLE>
<CAPTION>
                                                                                 FOR THE YEARS ENDED JUNE 30,            
                                                                                 1995       1996       1997
                                                                                 ----       ----       ----
<S>                                                                              <C>        <C>       <C>
Weighted average primary common shares outstanding during the year               6,876       9,872    12,923

Dilutive effect of shares assumed issued upon exercise of stock
options (less shares assumed purchased by the Company)                              14         298       312
                                                                                    --         ---       ---

Outstanding common shares for primary earnings per share calculation             6,890       10,170   13,235
                                                                                 =====       ======   ======

Weighted average fully diluted common shares outstanding during the year         6,876       11,576   13,352

Dilutive effect of shares assumed issued upon exercise of stock options
(less shares assumed purchased by the Company)                                      14          298      335
                                                                                    --          ---      ---

Outstanding common shares for fully diluted earnings per share calculation       6,890       11,874   13,687
                                                                                 =====       ======   ====== 
</TABLE>
### Proposed Provision: D6. For spouses and children of retired and disabled workers becoming newly eligible beginning in 2030 and phased in for 2030 through 2039, limit their auxiliary benefit to one-half of the PIA for a hypothetical worker with earnings equal to the national average wage index (AWI) each year.

back
#### Mutual Life Insurance Company v. John G. Sturges and others.

Motion granted as per order entered.
<TABLE> <S> <C>


        <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE 
COMPANY'S FORM 10-K AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO 
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                      <C>
<PERIOD-TYPE>		YEAR
<FISCAL-YEAR-END>				JUN-30-1997
<PERIOD-START>                      JUL-01-1996
<PERIOD-END>                        JUN-30-1997
<CASH>                              28
<SECURITIES>                        0
<RECEIVABLES>                       294
<ALLOWANCES>                        40
<INVENTORY>                         423
<CURRENT-ASSETS>                    711
<PP&E>					800
<DEPRECIATION>				0
<TOTAL-ASSETS>                      1,511
<CURRENT-LIABILITIES>               1,947
<BONDS>                             0
<PREFERRED-MANDATORY>               0
<PREFERRED>                         0
<COMMON>                            428
<OTHER-SE>                          (1,113)
<TOTAL-LIABILITY-AND-EQUITY>        1,511
<SALES>                             7,358
<TOTAL-REVENUES>                    7,358
<CGS>                               5,847
<TOTAL-COSTS>                       1,919
<OTHER-EXPENSES>                    0
<LOSS-PROVISION>                    0
<INTEREST-EXPENSE>                  122
<INCOME-PRETAX>                     (530)
<INCOME-TAX>                        0
<INCOME-CONTINUING>                 (530)
<DISCONTINUED>                      0
<EXTRAORDINARY>                     0
<CHANGES>                           0
<NET-INCOME>                        (530)
<EPS-PRIMARY>                       (.00)
<EPS-DILUTED>                       (.00)
Long-range 

actuarial 

balance

Annual 

balance in 

75th year

Long-range 

actuarial 

balance

Annual 

balance in 

75th year

Long-range 

actuarial 

balance

Annual 

balance in 

75th year

-3.61 -4.35 1.11 2.79 31% 64%

Estimates based on the intermediate assumptions of the 2023 Trustees Report Office of the Chief Actuary

Social Security Administration

September 15, 2023

Summary Measures and Graphs

Category of Change: Level of Monthly Benefits

Current law

[percent of payroll]

Change from current law

[percent of payroll] Shortfall eliminated

Proposed Provision: B1.4. Progressive price indexing (50th percentile) of PIA factors beginning with 

individuals newly eligible for OASDI benefits in 2030: Create a new bend point at the 50th percentile of the 

AIME distribution of newly retired workers. Maintain current-law benefits for earners at the 50th percentile 

and below. Reduce the 32 and 15 percent factors above the 50th percentile such that the initial benefit for 

a worker with AIME equal to the taxable maximum grows by inflation rather than the growth in the SSA 

average wage index.

6.0

8.0

10.0

12.0

14.0

16.0

18.0

20.0

2023 2030 2040 2050 2060 2070 2080 2090

Percent

Year

OASDI Cost Rates and Income Rates

(as a percentage of taxable payroll)

Income rates under current law

Income rates with this provision

Cost rates under current law

Cost rates with this provision

0

100

200

300

400

500

600

2023 2030 2040 2050 2060 2070 2080 2090

Percent

Year

OASDI Trust Fund Ratio

(assets as a percentage of annual expenditures)

Current law With this provision
[Federal Register Volume 60, Number 240 (Thursday, December 14, 1995)]
[Notices]
[Page 64175]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-30438]



-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health


Division of Research Grants; Notice of Closed Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
Division of Research Grants Special Emphasis Panel (SEP) meetings:

    Purpose/Agenda: To review individual grant applications.
    Name of SEP: Behavioral and Neurosciences.
    Date: December 15, 1995.
    Time: 12:00 p.m.
    Place: NIH, Rockledge 2, Room 5178, Telephone Conference.
    Contact Person: Dr. Joseph Kimm, Scientific Review 
Administrator, 6701 Rockledge Drive, Room 5178, Bethesda, Maryland 
20892, (301) 435-1249.

    Name of SEP: Behavioral and Neurosciences.
    Date: December 15, 1995.
    Time: 2:00 p.m.
    Place: NIH, Rockledge 2, Room 5182, Telephone Conference.
    Contact Person: Dr. Carl Banner, Scientific Review 
Administrator, 6701 Rockledge Drive, Room 5182, Bethesda, Maryland 
20892, (301) 435-1251.
    This notice is being published less than 15 days prior to the 
above meetings due to the urgent need to meet timing limitations 
imposed by the grant review and funding cycle.
    Name of SEP: Behavioral and Neurosciences.
    Date: February 21-23, 1996.
    Time: 8:00 a.m.
    Place: The Madison Hotel, Washington, D.C.
    Contact Person: Dr. David Simpson, Scientific Review 
Administrator, 6701 Rockledge Drive, Room 5192, Bethesda, Maryland 
20892, (301) 435-1278.

    Name of SEP: Biological and Physiological Sciences.
    Date: February 23, 1996.
    Time: 8:30 a.m.
    Place: Hyatt Regency, Bethesda, Maryland.
    Contact Person: Dr. Robert Weller, Scientific Review 
Administrator, 6701 Rockledge Drive, Room 5204, Bethesda, Maryland 
20892, (301) 435-1261.

    Name of SEP: Biological and Physiological Sciences.
    Date: March 1, 1996.
    Time: 8:30 a.m.
    Place: Hyatt Regency, Bethesda, Maryland.
    Contact Person: Dr. Robert Weller, Scientific Review 
Administrator, 6701 Rockledge Drive, Room 5204, Bethesda, Maryland 
20892, (301) 435-1261.
    The meetings will be closed in accordance with the provisions 
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program Nos. 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: December 8, 1995.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 95-30438 Filed 12-13-95; 8:45 am]
BILLING CODE 4140-01-M
```
[Federal Register Volume 61, Number 1 (Tuesday, January 2, 1996)]
[Notices]
[Page 62]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-31536]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY
[Docket No. CP96-101-000]

Williams Natural Gas Company; Notice of Request Under Blanket 
Authorization

December 26, 1995.
    Take notice that on December 8, 1995, Williams Natural Gas Company 
(WNG), P.O. Box 3288, Tulsa, Oklahoma 74101, filed in Docket No. CP96-
101-000 a request pursuant to Sections 157.205 and 157.216 of the 
Commission's Regulations under the Natural Gas Act (18 CFR 157.205, 
157.216) for authorization to (1) abandon by sale to Western Resources, 
Inc. (WRI) approximately 2.3 miles of 8-inch lateral pipeline and two 
meter settings located in Osage County, Oklahoma and approximately 0.57 
miles of 10-inch lateral pipeline located in Washington County, 
Oklahoma, and (2) to relocate the West Bartlesville town border to the 
site of WNG's high pressure regulator setting in Osage County, under 
WNG's blanket certificate issued in Docket No. CP82-479-000 pursuant to 
section 7 of the Natural Gas Act, all as more fully set forth in the 
request that is on file with the Commission and open to public 
inspection.
    Any person or the Commission's staff may, within 45 days after 
issuance of the instant notice by the Commission, file pursuant to Rule 
214 of the Commission's Procedural Rules (18 CFR 385.214) a motion to 
intervene or notice of intervention and pursuant to Sec. 157.205 of the 
Regulations under the Natural Gas Act (18 CFR 157.205) a protest to the 
request. If no protest is filed within the time allowed therefor, the 
proposed activity shall be deemed to be authorized effective the day 
after the time allowed for filing a protest. If a protest is filed and 
not withdrawn within 30 days after the time allowed for filing a 
protest, the instant request shall be treated as an application for 
authorization pursuant to section 7 of the Natural Gas Act.
Lois D. Cashell,
Secretary.
[FR Doc. 95-31536 Filed 12-29-95; 8:45 am]
BILLING CODE 6717-01-M
```
EXHIBIT 32.02



In connection with the Annual Report of Education Management Corporation (the Company) on Form 10-K for the fiscal year ended
June 30, 2003 as filed with the Security and Exchange Commission on the date hereof (the Report), I, Robert T. McDowell, Chief Financial Officer of the Company, hereby certify in such capacity pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:



1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and;



2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date: September 13, 2004



|                       
|-----------------------
|/s/ ROBERT T. MCDOWELL 
|Robert T. McDowell     
|Chief Financial Officer
Improving Opportunities for T

Who Want to Work Longe

Discussion by Steve Goss, Chief Actuary, SSA

Brookings Event 

January 24, 2019
Increasing Cost of Retirement is Due to Populat

(change in age distribution mainly due to drop in birt

0.000.050.100.150.200.250.300.350.400.450.50

1940 1950 1960 1970 1980 1990 2000 2010 2020 2030 2040 2050 2060 2070 2080 

Aged Dependency Ratio 2018 TR

Population 65+/(20-64) 

Actual and TR IntermediateTFR remains at 3.0 after 1964TFR remains at 3.3 after 1964
Where Has Employment Been Growing? Over Ag

So we need people to work more at all ages–not just olde

0

0.10.20.30.40.50.60.70.80.9

1

1980 1982 1984 1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010 2012 2014 2016

Male Ratio of Civilian Employment to Non-institutionalized Population

EPM2554 EPM5559 EPM6064 EPM6569 EPM70O

70 and over

65-69

60-64

55-59

25-54

0

0.10.20.30.40.50.60.70.80.9

1

1980 1982 1984 1986 1988 1990 1992 1994 1996 1998 2000 2002 

Female Ratio of Civilian Employment to Non

EPF2554 EPF5559 EPF6064 EPF

70 and over

65-69

60-64

55-59

25-54
Age of Starting Social Security Retirement Be

0

102030405060708090

100

1975 1980 1985 1990 1995 2000 2005 2010 2015

Male Retired Worker Beneficiaries In Current Payment 

Status as Percent of Insured Population 

(excluding those receiving only some other OASDI benefit)

62.5 63.5 64.5 65.5 66.5 67.5 68.5 69.5 70.5

Recession

Eliminate Earnings 

Test Over NRA

0

102030405060708090

100

1975 1980 1985 1990 1995 

Female Retired Worker Beneficia

Status as Percent of Insu

(excluding those receiving only som

62.5 63.5 64.5 65.5 66.5 

Eli
Proposals to Encourage Work to Highe

• Munnell/Walters:

• Expand EITC for individuals without dependent ch• Make people better informed

• Establish a “National Retirement Age” of 70

Would this lower benefits by 20%? How about Medicare 

• Report 401(k) income projections

Yes! Expected replacement rate for accruals to date?

• Workplace seminars on working longer

By employers? Even small employers?

• Reintroduce mandatory retirement age & public c

older workers
Proposals to Encourage Work to Highe

• Clark/Shoven:

• Eliminate earnings test between 62 (ERA) and 6

Start benefits earlier, lowering monthly benefit thereafter.

• Paid-up status; cease OASDI payroll tax and ben

accruals after 67 (NRA)

Shift more OASDI cost to younger workers? Lower their wagShift employer preference to older workers at expense of yo

• Paid-up status for Medicare, and make Medicare 

primary

•Other possibilities
Exhibit 32.2


CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO


18 U.S.C. SECTION 1350


AS ADOPTED PURSUANT TO SECTION 906


OF THE SARBANES-OXLEY ACT OF 2002, AS AMENDED


I, Kathleen M. Crusco, Executive Vice President and Chief Financial Officer of Activant Solutions Inc. (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, as amended, that, to the best of my knowledge:


|   |                                                                                                                                                                                                                                                                                                                    
|-- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|1. | the quarterly report on Form 10-Q of the Company for the three months endedDecember 31, 2010as filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”); and

|   |                                                                                                                                                     
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------
|2. | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 9, 2011


/s/ Kathleen M. CruscoName: Kathleen M. CruscoTitle: Executive Vice President and Chief Financial Officer


The foregoing certification which accompanies the Report is not deemed filed with the Securities and Exchange Commission for purposes of Section 18 of the Exchange Act and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
## Summary Measures and Graphs

- Individual Provisions
- Payroll Taxes (including maximum taxable)

### **Description of Proposed Provision:						E3.13: Beginning in 2031, apply 2 percent payroll tax rate on earnings over the wage-indexed equivalent of $400,000 in 2017 (about $696,600 in 2031), with the threshold wage-indexed after 2031. Do not provide benefit credit for additional earnings taxed.**

|  |  |
|--|--|